Pneumococcal synergism
(Unterschied zwischen Versionen)
(Die Seite wurde neu angelegt: „{{up|Immunology}} ---- Pneumococcal colonization means synergism with sars cov2 ad disease expression. 13-valent pneumococcal vaccination reduces death/severit…“) |
|||
| Zeile 11: | Zeile 11: | ||
until further humanized work by me, | until further humanized work by me, | ||
| − | {{plb|(covid19+OR+covid-19+OR+sars-cov2+OR+sars-cov-2+OR+2019-ncov+OR+2019ncov)&S2=pneumococc*+OR+streptococc*+OR+ | + | {{plb|(covid19+OR+covid-19+OR+sars-cov2+OR+sars-cov-2+OR+2019-ncov+OR+2019ncov)&S2=pneumococc*+OR+streptococc*+OR+#22s.pneumoniae#22|covid19 & pneumococci}} |
Version vom 25. April 2021, 17:24 Uhr
| Immunology |
Pneumococcal colonization means synergism with sars cov2 ad disease expression. 13-valent pneumococcal vaccination reduces death/severity/incidence by some 30 percent, upto 90 days preexposure to antibiotics similar. 13-valent vaccination reduces surface colonization bey pneumococci, 23 valent does not.
index paper is
| 33693636 2021. Prevention of COVID-19 among older adults receiving pneumococcal conjugate vaccine suggests interactions between Streptococcus pneumoniae and SARS-CoV-2 in the respiratory tract |
until further humanized work by me,
| & pneumococci&Z0%3D0&ZL%3D150&Y%3D&MTB%3D1&px1%3Dproxy.nationallizenzen.de living current stringent pubmed readout on {{{2}}} |
